arrow
D

Dirk Westermann

University of Freiburg
H指数:75
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inclisiran vs bempedoic acid for low-density lipoprotein cholesterol lowering in high-risk patients: the VICTORION-challenge trial

inclisiran与bempedoic酸在高风险患者中降低低密度脂蛋白胆固醇的疗效比较:VICTORION-challenge试验

2026-08-310
OAAI
Transcriptomic profiling identifies tumor necrosis factor receptor-associated factor (TRAF)-5 expression in human atherosclerotic plaques as a predictor of future cardiovascular events

转录组分析鉴定肿瘤坏死因子受体相关因子(TRAF)-5在人类动脉粥样硬化斑块中的表达作为未来心血管事件的预测因子

2026-08-240
OA
Immunological risk identified by single-cell multi-omics and cardiovascular outcomes

单细胞多组学鉴定的免疫风险与心血管结局

2026-08-140
OAAI
Timely hospital discharge in TAVI patients: towards a patient-centered care pathway

TAVI患者的及时出院:迈向以患者为中心的护理路径

2026-05-280
OAAI
Time- and dose-dependent high-sensitivity cardiac troponin-T to improve outcome prediction after TAVI: a multicenter cohort study

时间与剂量依赖性高敏心肌肌钙蛋白T以提高经导管主动脉瓣置换术后预后预测:一项多中心队列研究

2025-11-240
OAAI
Right Ventricular Contractility Predicts Clearance of Ascites After Transjugular Intrahepatic Portosystemic Shunt

右心室收缩力预测经颈静脉肝内门体分流术后腹水的清除

2025-11-080
PRE
Neutrophil extracellular traps and peptidylarginine deiminase 4-mediated inflammasome activation link diabetes to cardiorenal injury and heart failure

中性粒细胞胞外陷阱和肽精氨酸脱亚胺酶4介导的炎症小体激活将糖尿病与心血管损伤和心力衰竭联系起来

2025-11-010
PRE
ECG-based identification of COPD patients at risk for atrial fibrillation and its impact on adverse clinical outcomes—a subgroup analysis of the prospective multicenter COSYCONET cohort

基于ECG的COPD患者房颤风险识别及其对不良临床结局的影响——COSYCONET前瞻性多中心队列研究的亚组分析

2025-10-030
OAAI
NLRP3 mediates lipid-driven macrophage proliferation in established atherosclerosis

NLRP3介导脂质驱动的巨噬细胞增殖,在已建立的动脉粥样硬化中发挥作用

2025-09-160
OAAI
Inferior Vena Cava Ultrasound to Guide Decongestion in Acute Decompensated Heart Failure

下腔静脉超声指导急性失代偿性心力衰竭的脱水治疗

2025-09-090
PRE
GLP-1 receptor agonists in atherosclerotic cardiovascular disease and diabetes mellitus or obesity: investigation of the potential role in a German inpatient dataset

GLP-1受体激动剂在动脉粥样硬化性心血管疾病和糖尿病或肥胖症中的作用:基于德国住院患者数据集的研究

2025-08-210
OA